HAZLET, N.J. - eTradeWire -- In this symposium, an expert multidisciplinary faculty will provide insights into and interpretations of clinical data, and challenging cases will reinforce key elements of prudent management of major bleeding in patients taking DOACs and experiencing intracranial hemorrhage.

The educational objectives include:

• Interpret clinical evidence with a specific reversal agent targeting dabigatran
• Explain clinical trial data for a specific reversal agent for factor Xa inhibition
• Describe critical considerations in managing the patient experiencing intracranial hemorrhage while receiving a direct oral anticoagulant (DOAC)

Click here for more information

More on eTradeWire News

• Dustex Cleaning Services Sets a New Standard in Professional Cleaning Solutions
• International AI and Stock Media Companies Eye ProPics Canada Media Ltd's Digital Asset Catalogue
• International Firms Flock to Acquire ProPics Canada Media Ltd's Digital Asset Catalogue
• Tobu Railway Announces a Price Revision on the "NIKKO PASS All Area" and "NIKKO PASS World Heritage Area," from April 20, 2025
• Holabird will hold a massive four-day "Mint-State" Americana & Numismatics Auction, May 2nd-5th, online and live in Reno

CHAIR
Truman J. Milling, Jr., MD
Professor, Department of Clinical Sciences
Tilman J. Fertitta Family College of Medicine
University of Houston, Houston, Texas
Associate Professor
Departments of Neurology and Surgery and Perioperative Care
Dell Medical School at the University of Texas Austin
Austin, Texas

FACULTY
Anne Alexandrov, PhD, AGACNP-BC, ANVP-BC, CCRN, FAAN
Professor of Nursing and Neurology
The University of Tennessee Health Science Center
Memphis, Tennessee

Paul Dobesh, PharmD
Professor
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska

Joshua Goldstein, MD, PhD
Professor of Emergency Medicine
Harvard Medical School
Endowed Chair in Emergency Medicine Research
Massachusetts General Hospital
Boston, Massachusetts

This educational activity is intended for clinicians managing patients experiencing intracranial hemorrhage.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

More on eTradeWire News

• HOBA Tech Expands Partner Program to Meet Global Demand for Business Transformation Excellence
• Innovative Employee Appreciation Solutions by iRewardify
• Best Air Conditioning Repair Service Queen Creek Florence Arizona
• Flexi-View Lending Closes $20 Million Business Loan for Strategic Purchase in Frankfort, KY
• Meet a Local Author Standing Against Hate

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.